TO THE EDITOR: We greatly appreciate the Resource Document put together by the
American Psychiatric Association's Councils on Consultation-Liaison Psychiatry and …

TO THE EDITOR: I disagree with the global condemnation of the use of chronic high-dosage
opiates for treating pain patients expressed by Jon Streltzer, MD, and Luther Johansen, MD …

TO THE EDITOR: The editorial by O'Brien, et al. argues that classification of substance use
disorders should use the term “addiction” instead of “dependence,” which involves normal …

TO THE EDITOR: The article by Dr. Vanderlip and colleagues (1), published in the July 2016
issue of the Journal, provides a framework for extending psychiatrists' role into primary care …

TO THE EDITOR: Obsessive-compulsive symptoms, documented in as many as 25% of
schizophrenic patients, pose a substantial therapeutic challenge. The addition of …

To the Editor: Substantial evidence supports the antidepressant efficacy of opiates (1). This
report summarizes our open-label experience using the µ-opiate agonists oxycodone or …

TO THE EDITOR: We read with interest the article by Blanco et al.(1), titled,“Pain as a
Predictor of Opioid Use Disorder in a Nationally Representative Sample,” published in the …

To the Editor: I read with great interest the article by Mark Olfson, MD, MPH, and colleagues
(1). Although the study was well conducted, there is an alternative way of interpreting its …

To the Editor: As medical director of an inpatient substance use treatment facility operated by
University of North Carolina (UNC) Health, I supervise psychiatry residents who are …

TO THE EDITOR: As a recent graduate of residency and fellowship in psychiatry, I read the
article by David B. Merrill, MD, et al.(1) with great interest. I struggled to define my …